抗体药物结合物的链接器设计:全面的审查
Yaxin Lei1,2, Minglei Zheng1,2, Peng Chen1
1Henan Linker Technology Key Laboratory, College of Advanced Interdisciplinary Science and Technology, Henan University of Technology, NO. 100 Lianhua Street, Zhengzhou, 450001, China.
ChemMedChem
|May 28, 2025
概括
抗体-药物合物 (ADC) 提供向的癌症治疗. 链接器技术的进步是提高下一代治疗的ADC疗效和安全性的关键.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物结合化学 生物结合化学
背景情况:
- 抗体-药物合物 (ADC) 是一种向癌症治疗方法,将单克隆抗体与细胞毒性有效载荷相结合,以克服传统化疗的局限性.
- 目前已批准17种ADC用于治疗血液和固体瘤,证明了临床成功,但强调了优化治疗潜力的持续挑战.
- 链接元件对ADC的性能至关重要,它影响了血稳定性和瘤部位的向有效载荷释放.
研究的目的:
- 提供对抗体-药物联合体 (ADC) 中临床验证的链接技术的概述.
- 讨论ADC链接器设计的最新创新,重点关注改善治疗结果的关键参数.
- 通过对链接器策略及其影响的分析,为下一代ADC的合理设计提供见解.
主要方法:
- 在抗体-药物合物 (ADC) 开发中对临床批准的链接剂和新兴链接技术的审查.
- 分析连接器设计元素,包括药物释放触发器,生物结合策略,间隔器对水友性的影响,无痕释放和整体架构.
- 在ADC链接器功能的背景下讨论旁观者效应.
主要成果:
- 在过去十年中,链接器技术的进步显著改善了ADC的药理动力学,疗效和毒性概况.
- 特定的链接器设计特征,如药物释放机制和间隔器特性,直接影响ADC的性能.
- 了解链接器特征对于最大限度地提高ADC的治疗指数至关重要.
结论:
- 链接器技术是抗体-药物联合体 (ADC) 成功的关键决定因素,补充了抗体和有效载荷选择.
- 链接器设计的创新为开发更有效,更安全的ADC提供了有希望的途径.
- 进一步研究链接策略,包括旁观者效应,将指导下一代优质癌症疗法的开发.
更多相关视频
08:47Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
9.6K
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.9K
相关概念视频
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Antibody Structure
61.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.4K
Phase II Conjugation Reactions: Overview
359
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
359
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
